Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PsOsim: CHS-1420 vs Humira in Chronic Plaque Psoriasis
2015-000632-15Phase 3Completed
- Sponsor
- Coherus BioSciences, Inc.
- Start
- Jun 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in plaque psoriasis and psoriasis comparing CHS-1420 arm with Humira arm (2 arms). Primary endpoint: PASI-75 at week 12. Started Jun 2015; status: completed.
02
Drugs
adalimumabadalimumab aqvh
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on 2015-000632-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000632-15.